- Home
- CELZ vs MBRX Comparison
CELZ vs MBRX Comparison
Compare CELZ & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELZ
- MBRX
- Stock Information
- Founded
- CELZ 1998
- MBRX 2015
- Country
- CELZ United States
- MBRX United States
- Employees
- CELZ N/A
- MBRX N/A
- Industry
- CELZ Biotechnology: Pharmaceutical Preparations
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- CELZ Health Care
- MBRX Health Care
- Exchange
- CELZ Nasdaq
- MBRX Nasdaq
- Market Cap
- CELZ 4.4M
- MBRX 5.1M
- IPO Year
- CELZ N/A
- MBRX 2016
- Fundamental
- Price
- CELZ $3.76
- MBRX $1.23
- Analyst Decision
- CELZ
- MBRX Strong Buy
- Analyst Count
- CELZ 0
- MBRX 2
- Target Price
- CELZ N/A
- MBRX $24.00
- AVG Volume (30 Days)
- CELZ 58.4K
- MBRX 38.4K
- Earning Date
- CELZ 03-21-2025
- MBRX 03-21-2025
- Dividend Yield
- CELZ N/A
- MBRX N/A
- EPS Growth
- CELZ N/A
- MBRX N/A
- EPS
- CELZ N/A
- MBRX N/A
- Revenue
- CELZ $11,000.00
- MBRX N/A
- Revenue This Year
- CELZ N/A
- MBRX N/A
- Revenue Next Year
- CELZ N/A
- MBRX N/A
- P/E Ratio
- CELZ N/A
- MBRX N/A
- Revenue Growth
- CELZ N/A
- MBRX N/A
- 52 Week Low
- CELZ $1.96
- MBRX $0.40
- 52 Week High
- CELZ $10.28
- MBRX $6.24
- Technical
- Relative Strength Index (RSI)
- CELZ 76.18
- MBRX 31.81
- Support Level
- CELZ $3.00
- MBRX $1.33
- Resistance Level
- CELZ $3.50
- MBRX $1.82
- Average True Range (ATR)
- CELZ 0.33
- MBRX 0.13
- MACD
- CELZ 0.14
- MBRX -0.02
- Stochastic Oscillator
- CELZ 93.71
- MBRX 13.17
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.